MicroStrategy Acquires $2.1B Worth of Bitcoin, Total Holdings Now Exceed 423,000 BTC Ivar AI

Ambcrypto.com

Crypto market cap surpasses France, UK GDPs – India, Japan next

The Daily Hodl

Trader Turns $3,000 Investment Into $73,000,000 With Frog-Themed Memecoin PEPE: Lookonchain

The Daily Caller

US, Israel Conduct Over 75 Strikes In Wake Of Syria’s Regime Collapse

Pragmatismopolitico.com.br

João Pessoa é a capital com maior desigualdade de renda do país, aponta IBGE

CNA

China sends largest naval fleet in decades to region, threat level severe, Taiwan says

Noticiaslatam.lat

¿Cómo la industria automotriz de China podría afectar al mercado mundial del petróleo?

Www.abc.es

Las empresas constructoras españolas solidifican su sueño americano

CryptoSlate

DeFi lending on Liquidium hits 4-month high as Bitcoin soars past $100K

The Irish Times

Israel moves tanks into Golan Heights demilitarised zone and strikes ‘strategic targets’ in Syria

The Times of India

Indian entertainment-media industry to grow 8.3% CAGR to reach Rs 3.7 trillion by 2028: PwC report

GlobeNewswire

TECVAYLI®▼ (teclistamab) demonstrates potential as frontline combination therapy for patients with newly diagnosed multiple myeloma

The Daily Hodl

Treasury Department’s FSOC Says Stablecoins Represent Potential Risk to US Financial Stability

Newser

Google Claims 'Mind-Boggling' Advance in Computing

La Nacion

La guerra comercial entre China y EE.UU. impactará de lleno en la producción tecnológica mundial

Investor's Business Daily

Rambus Stock Is In A Buy Zone With Its Profits Soaring

Biztoc.com

Alexis Ohanian Says This Is His Best Investment So Far: $10,000 Turned Into More Than $17 Million

$Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma$

GlobeNewswire

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Biztoc.com

Google Flexes Its Tech Muscles With Quantum Computing Chip, Waymo

$Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients$

GlobeNewswire

Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients

Biztoc.com

Ford And GM Lose To Japanese Rivals In Car Quality Survey